Meissa Vaccines

Meissa Vaccines

Biotechnology, 1100 Is Dr, Downtown Redwood City, California, 94065, United States, 11-50 Employees

meissavaccines.com

  • twitter
  • LinkedIn

phone no Phone Number: 65********

Who is MEISSA VACCINES

Meissa is a private biotech company focused on the advancement of vaccines for respiratory viruses. Meissa was founded on proprietary technologies employing reverse genetics for rational ...

Read More

map
  • 1100 Is Dr, Downtown Redwood City, California, 94065, United States Headquarters: 1100 Is Dr, Downtown Redwood City, California, 94065, United States
  • 2014 Date Founded: 2014
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $5 Million to $10 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731 | NAICS Code: 325414 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from MEISSA VACCINES

Meissa Vaccines Org Chart and Mapping

Employees

Janelle Muranaka

Vice President of Operations

Martin Moore

Chief Scientific Officer

Oliver Medzihradsky

Senior Director, Clinical Development

Joseph Sulovski

Sr. Director of Clinical Operations

Xing Cheng

Associate Director of Virology

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Meissa Vaccines

Answer: Meissa Vaccines's headquarters are located at 1100 Is Dr, Downtown Redwood City, California, 94065, United States

Answer: Meissa Vaccines's phone number is 65********

Answer: Meissa Vaccines's official website is https://meissavaccines.com

Answer: Meissa Vaccines's revenue is $5 Million to $10 Million

Answer: Meissa Vaccines's SIC: 8731

Answer: Meissa Vaccines's NAICS: 325414

Answer: Meissa Vaccines has 11-50 employees

Answer: Meissa Vaccines is in Biotechnology

Answer: Meissa Vaccines contact info: Phone number: 65******** Website: https://meissavaccines.com

Answer: Meissa is a private biotech company focused on the advancement of vaccines for respiratory viruses. Meissa was founded on proprietary technologies employing reverse genetics for rational design of more effective live attenuated vaccines. The technology is exclusively licensed from Emory University and Childrens Healthcare of Atlanta. Dr. Moore, together with Dr. Roderick Tang, a vaccine biotech expert, co-founded Meissa. They are supported by a team with extensive experience in all aspects of vaccine development. Meissa is currently a resident company at the Johnson & Johnson Innovation JLABS in South San Francisco.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access